A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Deciphera Pharmaceuticals, LLC
Deciphera Pharmaceuticals, LLC
Dong-A ST Co., Ltd.
National Cancer Institute (NCI)
Chong Kun Dang Pharmaceutical
Case Comprehensive Cancer Center